134 related articles for article (PubMed ID: 23574301)
1. Ovarian function in female survivors of childhood malignancies.
El-Shalakany AH; Ali MS; Abdelmaksoud AA; Abd El-Ghany S; Hasan EA
Pediatr Hematol Oncol; 2013 May; 30(4):328-35. PubMed ID: 23574301
[TBL] [Abstract][Full Text] [Related]
2. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
3. [Anti-mullerian hormone in young women after chemotherapy and infradiaphragmatic radiotherapy for childhood cancer].
Krawczuk-Rybak M; Leszczyńska E; Wysocka J; Zelazowska-Rutkowska B
Pediatr Endocrinol Diabetes Metab; 2008; 14(2):99-103. PubMed ID: 18721496
[TBL] [Abstract][Full Text] [Related]
4. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
Lunsford AJ; Whelan K; McCormick K; McLaren JF
Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
[TBL] [Abstract][Full Text] [Related]
5. [Ovarian function in young women after anticancer treatment in childhood].
Krawczuk-Rybak M; Leszczyńska E; Zelazowska-Rutkowska B; Wysocka J
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1028-34. PubMed ID: 19531821
[TBL] [Abstract][Full Text] [Related]
6. Acute onset of ovarian dysfunction in young females after start of cancer treatment.
Mörse H; Elfving M; Lindgren A; Wölner-Hanssen P; Andersen CY; Øra I
Pediatr Blood Cancer; 2013 Apr; 60(4):676-81. PubMed ID: 23015461
[TBL] [Abstract][Full Text] [Related]
7. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
[TBL] [Abstract][Full Text] [Related]
8. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
9. Age at menarche: a predictor of diminished ovarian function?
Weghofer A; Kim A; Barad DH; Gleicher N
Fertil Steril; 2013 Oct; 100(4):1039-43. PubMed ID: 23809497
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
11. Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
Molgaard-Hansen L; Skou AS; Juul A; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2013 Dec; 60(12):1988-95. PubMed ID: 24038890
[TBL] [Abstract][Full Text] [Related]
12. Low serum concentrations of anti-Müllerian hormone are common in 53 female childhood cancer survivors.
Miyoshi Y; Ohta H; Namba N; Tachibana M; Miyamura T; Miyashita E; Hashii Y; Oue T; Isobe A; Tsutsui T; Kimura T; Ozono K
Horm Res Paediatr; 2013; 79(1):17-21. PubMed ID: 23295306
[TBL] [Abstract][Full Text] [Related]
13. Measuring ovarian function in young cancer survivors.
Su HI
Minerva Endocrinol; 2010 Dec; 35(4):259-70. PubMed ID: 21178920
[TBL] [Abstract][Full Text] [Related]
14. The progressive reduction in the ovarian reserve in young women after anticancer treatment.
Krawczuk-Rybak M; Leszczynska E; Poznanska M; Zelazowska-Rutkowska B; Wysocka J
Horm Metab Res; 2013 Oct; 45(11):813-9. PubMed ID: 23950034
[TBL] [Abstract][Full Text] [Related]
15. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the serum luteinizing hormone to folliclestimulating hormone ratio and the anti-Müllerian hormone levels in normo-ovulatory women.
Lee JE; Yoon SH; Kim HO; Min EG
J Korean Med Sci; 2015 Mar; 30(3):296-300. PubMed ID: 25729253
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of antimüllerian hormone in women with regular menstrual cycles.
Zec I; Tislarić-Medenjak D; Bukovec-Megla Z; Harni V; Kusić Z
Acta Clin Croat; 2010 Dec; 49(4):405-9. PubMed ID: 21830451
[TBL] [Abstract][Full Text] [Related]
18. Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study.
Hamre H; Kiserud CE; Ruud E; Thorsby PM; Fosså SD
Pediatr Blood Cancer; 2012 Aug; 59(2):271-7. PubMed ID: 22021108
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of ovarian status in women who received anti-tumor therapy in childhood and adolescence].
Roshchina NV; Tsyrlina EV; Punanov IuA; Safonova SA; Bershteĭn LM; Kostromina EV; Malinin AP; Morozova EV
Vopr Onkol; 2014; 60(3):360-5. PubMed ID: 25033691
[TBL] [Abstract][Full Text] [Related]
20. Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients.
Bozza C; Puglisi F; Lambertini M; Osa EO; Manno M; Del Mastro L
Endocr Relat Cancer; 2014 Feb; 21(1):R51-65. PubMed ID: 24292601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]